CNN Money reports the good news that the bull market isn’t over just yet: “Dow soars 432 points. The bull market’s not over yet.” So says Fake News CNN. However, personally I’m still thinking the advance that began in March 2009, ten
November 4, 2018
If the US/China trade war was the cause of the October selling, then the start of November has more to go as this narrative turns to deal making. The relief rally back in risk assets is the first chapter of
by Nick Cawley , Analyst Fundamental Forecast for GBP: Neutral STERLING (GBP) TALKING POINTS: Positive Brexit ‘talk’ boosts Sterling sentiment. Provisional Q3 GDP data may underpin GDP. We remain neutral on Sterling going into next week but acknowledge that GBP may push higher if the current,
Gold threatens more bull pressure as it looks to re-target the 1,243.41 resistance zone. On the downside, support comes in at the 1,220.00 level where a break will turn attention to the 1,210.00 level. Further down, a cut through here
This week is likely to see a similar level of activity to last week, with central bank input due for the U.S., Australian, and New Zealand Dollars. There will also be key data regarding the British Pound. The market is
The Australian dollar enjoyed a comeback week alongside stocks. Hopes for a deal between the US and China certainly helped. What’s next? The RBA stands out in the upcoming week. Here are the highlights of the week and an updated technical analysis for
Gold’s last three weekly settles have respectively been: 1230, 1236, and now Friday at 1235. Moreover, Gold has settled in the 1230’s for eight of the last 11 trading days. “BUT“… Come Tuesday’s stateside election results during which the late-night
USD/JPY failed to break below the bottom support trend line of the price channel on the daily chart, suggesting that the pair remains in the uptrend from 104.63 and another rise towards 115.50 resistance would likely be seen. Only a
Fundamental Forecast for EUR/USD: Neutral The Euro continued its streak of weakness, losing ground to five of the other seven major currencies as the calendar turned from October to November. There are no ‘high’ rated German or Eurozone data releases in the coming
Exact Sciences Corporation (EXAS – Research Report) is a groundbreaking med tech company focused on developing screening tests for early stage cancer. This results in earlier detection and better treatment outcomes for patients. Established back in 1995, EXAS received FDA approval for
